Skip to main content

Table 3 Identification results of potential biomarkers

From: Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease

Mode

RT

Measured mass

VIP

Formula

Error (ppm)

Identification

Trenda

ESI+

7.19

206.0438

4.78

C10H7NO4

1.0

Xanthurenic acid

up

 

2.59

338.1134

3.07

C7H14N2O6S

3.0

5-L-Glutamyl-taurine

up

 

2.30

105.0414

2.91

C10H18N4O6

-6.7

Argininosuccinic acid

down

 

1.18

220.1181

2.86

C9H17NO5

0.9

Pantothenic acid

up

 

1.93

162.0673

2.80

C12H22N2O6S

0.6

D-Pantothenoyl-L-cysteine

down

 

0.51

191.0206

2.18

C6H8O7

-2.0

Citric acid

up

 

3.08

164.0711

2.13

C9H9NO2

-3.0

3-Methyldioxyindole

up

 

8.04

426.3567

1.77

C25H47NO4

2.6

Vaccenyl carnitine

up

 

1.70

135.0641

1.70

C5H10O4

-8.1

2,3-Dihydroxyvaleric acid

down

ESI-

2.74

143.1067

6.68

C8H16O2

-7.7

Caprylic acid

up

 

0.48

167.0201

3.11

C5H4N4O3

6.0

Uric acid

down

 

6.37

377.1454

2.79

C17H20N4O6

0.8

Riboflavin

up

 

3.30

173.0808

2.32

C8H14O4

-6.4

Suberic acid

down

 

0.40

124.0067

2.29

C2H7NO3S

6.4

Taurine

up

 

1.13

154.0505

1.53

C7H7NO3

2.6

3-Hydroxyanthranilic acid

up

 

2.24

157.0882

1.28

C8H14O3

1.9

3-Oxooctanoic acid

down

  1. Metabolite change trend in MHG compared with MG